Creating products and solutions for legal retail and commercial cannabis growers Customers include retail stores, distributors, ecommerce and commercial growers S. legal cannabis market projected to reach $11 billion in consumer spending in 2018 and more than $23 billion by 2022, with potential to generate more than 467,000 full-time equivalent jobs in 2022. Focused approach … Continue reading “Generation Alpha, Inc. (GNAL) is “One to Watch””
Vertically integrated cannabis technology company Generation Alpha, Inc. (OTCQB: GNAL) this morning announced its operating results for the three and nine months ended September 30, 2018. Among the highlights from the nine-month period, Generation Alpha reported $2.6 million in revenue from its lighting and nutrient offerings, as well as a cash balance of $2.1 million. … Continue reading “CannabisNewsBreaks – Generation Alpha, Inc. (GNAL) Highlights Third Quarter 2018 Operating Results”
CannabisNewsWire Editorial Coverage: Recent U.S. government interest in ensuring industrial hemp supply signals a period of growth for the cannabinoid industry. Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile) is contributing to this growth through new hemp cultivation projects in both Canada and the U.S., to support its hempSMART subsidiary. Cronos Group Inc. (TSX: … Continue reading “Government Interest in Hemp Diversity Signals Strong Future for American Cannabis Industry”
Signal Bay (OTC: SGBY) provides advisory, management and analytical testing services to the legalized cannabis industry in the United States. The company offers industry research, business and market intelligence, market forecasts and operational insights; and advisory and consulting services, including license application support, regulatory compliance, and operating services for current and prospect licensed cannabis businesses. … Continue reading “Signal Bay, Inc. (SGBY) Starts Presentation at LD Micro 2017 Invitational”
Signal Bay (OTC: SGBY) provides advisory, management and analytical testing services to the legalized cannabis industry in the United States. The company offers industry research; business and market intelligence; and advisory and consulting services, including license application support, regulatory compliance, market forecasts and operational insights. It also publishes industry information through online media, research reports … Continue reading “Signal Bay (SGBY) Starts Presentation at LD Micro Main Event”
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of cannabinoid receptor 1 (“CB1”) and cannabinoid receptor 2 (“CB2”). The reported data continues to demonstrate … Continue reading “CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD”
The United States anticipates surpassing $31 billion in regulated cannabis sales this year, according to recent projections from Whitney Economics, a hemp and cannabis consulting company based in Portland, Oregon. The estimate suggests that recreational and medical cannabis legal sales will reach approximately $31.4 billion this year, marking a $2.6 billion rise from the previous … Continue reading “420 with CNW — US Marijuana Sales Expected to Be in Excess of $31B in 2024”
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting additional preclinical data demonstrating the positive effects of its INM-901 for the potential treatment of Alzheimer’s disease (“AD”). Highlights of the report note that INM-901 receptor binding studies indicate preferential signaling agonism for both … Continue reading “CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Favorable Results from INM-901 Preclinical AD Studies”
Chuck Schumer, the Senate Majority Leader, is rallying public support for a bill focused on facilitating banking services for cannabis-related businesses through an online petition. In a recent communication concerning this endeavor, he reaffirmed his stance in favor of a comprehensive federal legalization of marijuana. In the wake of continuing congressional discussions on budgetary appropriations, … Continue reading “420 with CNW — Schumer Sends Out Petition Urging Public to Express Support for Cannabis Banking Legislation”
Alcohol use disorder (AUD) is a condition characterized by the impaired ability to control or stop the use of alcohol despite adverse health, occupational or social consequences. A recent scientific review on cannabidiol (CBD) and its effects suggests that the compound may help manage symptoms of alcohol use disorder. CBD is one of the two … Continue reading “Scientific Review Finds Potential for CBD to Manage AUD Symptoms”